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Background: Red ginseng and ginsenosides have shown plethoric effects against various ailments.
However, little is known regarding the effect of red ginseng on morphine-induced dependence and
tolerance. We therefore investigated the effect of red ginseng extract (RGE) and biotransformed ginse-
nosides Rh2, Rg3, and compound K on morphine-induced dependence in mice and rats.
Methods: While mice were pretreated with RGE and then morphine was injected intraperitoneally, rats
were infused with ginsenosides and morphine intracranially for 7 days. Naloxone-induced morphine
withdrawal syndrome was estimated and conditioned place preference test was performed for physical
and psychological dependence, respectively. Western blotting was used to measure protein expressions.
Results: Whereas RGE inhibited the number of naloxone-precipitated jumps and reduced conditioned
place preference score, it restored the level of glutathione in mice. Likewise, ginsenosides Rh2, Rg3, and
compound K attenuated morphine-dependent behavioral patterns such as teeth chattering, grooming,
wet-dog shake, and escape behavior in rats. Moreover, activated N-methyl-D-aspartate acid receptor
subunit 1 and extracellular signal-regulated kinase in the frontal cortex of rats, and cultured cortical
neurons from mice were downregulated by ginsenosides Rh2, Rg3, and compound K despite their dif-
ferential effects.
Conclusion: RGE and biotransformed ginsenosides could be considered as potential therapeutic agents
against morphine-induced dependence.
Copyright  2016, The Korean Society of Ginseng, Published by Elsevier. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Beneﬁts of opioid therapy for acute and chronic pain leads to
their frequent use; however, opioids such as morphine have been
associated with increased abuse, misuse, and overdose [1] accom-
panied by the risk of tolerance, dependence, and illicit diversion [2].
Pharmacological studies conducted so far have identiﬁed a number
of signaling proteins involved in morphine-induced tolerance and
dependence, including the N-methyl-D-aspartate acid receptor
(NMDAR), nitric oxide synthase [3], protein kinase C, protein kinase
A (PKA), calcium (Ca2⁺)/calmodulin-dependent kinase II, delta-
opioid receptor, and regulators of G-protein signaling proteins.
The G protein-coupled m-opioid receptor and NMDAR-mediated
signals work together in a sequential and interconnected manner
to ultimately induce m-opioid receptor desensitization [4e6].
Extracellular signal-regulated kinases (ERKs) have been shown toedicine, School of Medicine, Ewh
ht  2016, The Korean Society of G
d/4.0/).be activated [7e9], and NMDAR subunit 1 (NR1) modulation was
reported in morphine dependence [10].
A major goal of research on drug abuse is to develop effective
treatments to deal with long-term behavioral disorders, especially
reinstatement induced by abused drugs such as morphine. In this
regard, phytochemicals obtained from medicinal herbs possess the
capability to plague molecular mechanisms of tolerance, depen-
dence, and addiction induced by abused drugs [11], or to enhance
processes of their detoxiﬁcation in the liver [12] and increase the
physical and intellectual work capacity by their actoprotective ef-
fect [13]. Red ginseng and its active components, ginsenosides, have
shown plethoric effects against various ailments [14]. It is well
known that ginsenosides can be biotransformed by intestinal
microﬂora and the metabolites would be absorbed into blood
vessels. While incubation of ginseng protopanaxadiol saponins
(Rb1, Rb2, and Rc) with human intestinal bacteria gives rise toa Womans University, Seoul 07985, Korea.
inseng, Published by Elsevier. This is an open access article under the CC BY-NC-ND
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metabolite [15].
Ginsenosides Rh2, Rg3, and compound K have been reported for
apoptosis [16,17] and anticancer [18e20], anti-inﬂammatory
[21,22], and antidepressant-like effects [23]. Previous reports
indicated that ginsenosides with different structures have antago-
nizing properties in the regulation of morphine-induced rein-
forcement [24]. Despite the potential effects of ginsenosides on
morphine dependence and tolerance reported so far, little is known
regarding the effects of red ginseng extract (RGE) on morphine-
induced behavioral disorders. Moreover, there is paucity of data
pertaining to the effects of biotransformed ginsenosides such as
Rh2, Rg3, and compound K on activated NR1 and ERK1/2. Therefore,
this study revealed that RGE and ginsenosides (Rh2, Rg3, and
compound K) ameliorate morphine-induced abnormal behaviors
with restoration of hepatic glutathione level. Expressions of phos-
phorylated NR1 and ERK in the frontal cortical tissues of rats were
also attenuated by Rh2, Rg3, and compound K.
2. Materials and methods
2.1. Materials
RGE was obtained from KT&G Central Research Institute in Ko-
rea, morphine hydrochloride from Myungmun Pharm (Seoul, Ko-
rea), and naloxone hydrochloride from Sigma-Aldrich (St. Louis, MO,
USA); compound K, 20(S)-ginsenoside Rg3, and 20(S)-ginsenoside
Rh2 were prepared as described previously [15]. All other chem-
icals, reagents, and antibodies were obtained from Sigma-Aldrich.
2.2. Animals and treatments
Both C57BL/6 male mice and male Sprague-Dawley rats were
obtained from Daehan Biolink (Eumsung, Korea). Animals were
housed and acclimatized (1 wk) on a 12-h lightedark cycle and
maintainedat 24 3Cwith freeaccess to chowandwater. All animal
procedures were in accordance with the Institutional Animal Care
andUse Committee of EwhaWomansUniversity, School ofMedicine.
2.3. Treatments in mice
Mice (23 2 g) were randomly assigned to each group and were
given saline, morphine (10 mg/kg, i.p.), or both morphine and RGE
(250 mg/kg and 500 mg/kg, p.o.) daily for 7 d. RGE was adminis-
tered 30 min prior to the injection of morphine. Naloxone hydro-
chloride (5e10mg/kg, i.p.) was injected 6 h after the ﬁnal morphine
injection for induction of morphine withdrawal syndrome in mice
and rats.
2.4. Treatments in rats
Rats (220e240 g) were implanted with guide cannulae for drug
infusion. Rats were anesthetized by intramuscular injection of ke-
tamine (50 mg/kg) and xylazine (1 mg/kg), before performing
standard stereotaxic surgery on a Kopf stereotaxic frame. A 21-
gauge stainless-steel cannula was implanted in the right lateral
ventricle (L: 1.3 mm; AeP: e0.5 mm; and DeV: e4.3 mm) of the rat
brain with the bregma chosen as the stereotaxic reference point.
The cannula was held in place with rapid-setting dental acrylic
(Lang Dental Mfg. Co., Chicago, IL, USA) anchored to the skull by a
plastic protective cap. Rats were allowed 1 wk for recovery before
implantation of osmotic mini-pumps. The mini-pump was
implanted subcutaneously as described previously, with minor
modiﬁcations [15]. Brieﬂy, under ether anesthesia, a small cut was
made behind the ears of a rat, and the subcutaneous space wasexpanded with hemostatic forceps. Saline vehicle or ginsenoside
was ﬁltered through a 0.2 mm sterile syringe ﬁlter and was then
used to ﬁll an osmotic mini-pump (Alzet 2ML 1; Alza, Palo Alto, CA,
USA). The mini-pump, which contains ginsenoside Rg3, Rh, or
compound K, was implanted and connected directly to the
morphine osmotic pump via 6-cm long PE-60 polyethylene tubing.
The infusion rate was 10 mg/10 mL/h for 7 d. The incision on the back
was closed with cyanoacrylate glue, and dental acrylic was layered
on top of the polyethylene tube.
2.5. Measurement of morphine withdrawal syndrome
Morphine withdrawal syndrome in mice was induced by an
injection of naloxone (5 mg/kg). Immediately after naloxone in-
jection, mice were placed into individual observation cylinders
(25 cm in diameter and 50 cm in height), and the frequency of
jumps of each mouse was observed for 30 min. In rats, naloxone-
induced morphine withdrawal syndrome was estimated 6 h after
stopping the morphine infusion. The withdrawal syndrome was
initiated by naloxone (10 mg/kg, i.p.) and rats were kept in plastic
cages for 30 min to observe withdrawal symptoms such as wet-dog
shake, escape behavior, grooming, and teeth chattering.
2.6. Conditioned place preference test
Conditioned place preference (CPP) test was used to evaluate
the development of morphine-induced psychological dependence
in mice. The CPP apparatus was composed of two square-based
plexiglass compartments, one with white and the other with
black walls, which could be separated by guillotine doors. A
computer-based video-tracking system was used to record and
analyze the behavioral data. The CPP test consisted of three phases:
preconditioning, conditioning, and postconditioning. On the 1st day
(Day 1) of the preconditioning phase, all mice were individually
placed into the apparatus for 15 min. The guillotine doors were
raised, allowing the animal a free access to both compartments. On
the 2nd day (Day 2), the time spent in each chamber was recorded
for 15 min and analyzed. The conditioning phase occurred over a
period of 6 d. During this phase, the guillotine doors were closed.
Each day, half of the mice in each group were conﬁned to the black
compartment and the other half to the white compartment. Mice
were trained for 6 consecutive days. On Days 3, 5, and 7, mice
received the drug just prior to being conﬁned for 30 min in the
compartment that they less preferred. On Days 4, 6, and 8, mice
received saline just prior to being conﬁned for 30 min to the
compartment that they favored. During the postconditioning phase
(Day 9), the guillotine doors were raised, and the untreated rats
were placed in the tunnel in the central part of the apparatus. The
time that rats spent in each compartment was recorded for 15 min.
CPP scores were expressed as the difference in the preconditioning
and postconditioning phases. All experiments were carried out
between 2 and 5 PM.
2.7. Measurement of liver glutathione contents in mice
Mice were killed by decapitation on the 7th day of the experi-
ment. The liver was removed immediately, and glutathione con-
centration was determined using Ellman method as follows: wet
liver was homogenized in four volumes of 0.5M sodium phosphate
buffer, pH 7.4, and then 0.5 mL was deproteinized by addition of
0.5 mL of 4% trichloroacetic acid containing 1mM Na-EDTA and
centrifuged at 3,000g for 5 min at 4C. The supernatant (0.5 mL)
was added to 4.5 mL of 0.1mM 5,50-dithiobis(2-nitrobenzoic acid)
and allowed to stand for 20 min at room temperature. The reaction
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Fig. 1. Effects of red ginseng extract on naloxone-precipitated jumping behavior in
morphine-dependent mice. RGE (250 mg/kg and 500 mg/kg, p.o.) were administered
30 min before morphine injection (10 mg/kg, i.p., n¼ 10) for 7 d. On the 7th day,
naloxone (5 mg/kg, i.p.) was injected 6 h after ﬁnal morphine administration. The
number of jumps in 30 min was counted after naloxone injection. Data were expressed
as mean SD (n¼ 10). ## p< 0.001 in comparisonwith the control group. ** p< 0.01 in
comparison with the saline (morphine only) group. Con, control; RGE, red ginseng
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Fig. 2. The effect of RGE pretreatment against morphine-induced psychological
dependence in mice. Mice were treated with RGE (250 mg/kg and 500 mg/kg, i.p.),
morphine (10 mg/kg, i.p.), or RGE and morphine. The time that mice spent in each
compartment of the CPP apparatus was recorded for 15 min. The CPP scores were
calculated by taking the difference between preconditioning and postconditioning
phases. Data were expressed as mean SD (n¼ 8). ## p< 0.05 compared with the
control group (each group, n¼ 8). ** p< 0.01 compared with the morphine-only group.
CPP, conditioned place preference; Con, control; RGE, red ginseng extract; Sal, saline;
SD, standard deviation.
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Cortical cell culturewas prepared from C57BL/6mice embryo at a
gestational age of 15 d. The brainwas dissected; cortical tissues were
taken out and dissociated in ice-cold buffer to prepare cell suspen-
sion, which was centrifuged at 1,000 rpm for 5 min, and then cell
pellets were resuspended in Minimum Essential Medium (MEM)
(Gibco BRL, Rockville, MD, USA) supplemented with 5% heat-
inactivated fetal calf serum (Gibco BRL); the cells were cultured in
an incubator at 5% CO2 at 37C for 7 d. Then, the cells were treated
with 10 mM cytosine arabinofuranoside (Ara C) to reduce the growth
of contaminatingnon-neuronal cells. The cortical neuronal cellswere
cultured in MEM containing 10% horse serumwithout glutamine.
2.9. Western immunoblotting
Protein concentrations in whole cell lysates or brain tissues
were determined using a protein assay kit (Pierce Biotechnology,
Rockford, IL, USA). Sample buffer (4) was added to the extract and
boiled for 15 min at 100C. Proteins (30e60 mg) underwent elec-
trophoresis on 10% or 8% sodium dodecyl sulfate polyacrylamide gel
and were transferred to polyvinylidene diﬂuoride membrane. The
blots were then blocked with 5% fat-free dry milk-tris-buffered
saline containing 0.1% Tween-20 (TBST) buffer for 1 h and incu-
bated with primary antibodies (ERK1/2, 1:1,000; pERK1/2, 1:2,000;
NR1, 1:1,000; pNR1, 1:1,000; Santa Cruz Biotechnology, CA, USA) at
4C overnight. After washing three times with TBST, the blots were
incubated with horseradish peroxidase-conjugated secondary an-
tibodies (1:2,000) in 3% fat-free dry milk-TBS for 1 h at room
temperature. The blots were rinsed again three times with TBST,
and the transferred proteins were incubated with the enhanced
chemiluminescent detection kit according to the manufacturer’s
instructions and visualized with Imagequant LAS 4000 (Fujiﬁlm
Life Science, Tokyo, Japan).
2.10. Statistical analysis
All values were expressed as mean standard deviation values.
Results were subjected to a one-way analysis of the variance by the
NewmaneKeuls multiple comparison test. Differences with
p< 0.05 and p< 0.01 were considered statistically signiﬁcant. All
analyses were performed using SPSS version 15.0 for Windows
(SPSS Inc., Chicago, IL, USA).
3. Results
3.1. RGE reduced morphine-related physical dependence in mice
Morphine-induced physical dependence is associated with
jumping behavior after injection of naloxone (5 mg/kg) in mice.
Here, we observed that morphine-treated groups of mice showed
thehighest frequencyof jumping (40)within 30min comparedwith
the groups treated with saline or RGE (500 mg/kg) only. RGE pre-
treatment at a dosage of 250mg/kg reduced the number of jumps by
half in morphine-treated mice, and this effect was highly dimin-
ished when the mice were subjected to 500 mg/kg RGE (Fig. 1).
3.2. RGE ameliorated morphine-induced psychological dependence
in mice
One of the withdrawal symptoms of morphine injection is
psychological dependence. To determine if mice pretreated with
RGE and then injected with morphine were less likely to develop
psychological dependence, the CPP test was used. Mice treated
with morphine showed a higher CPP test score (3 times) than thosetreated with RGE at 250 mg/kg. RGE pretreatment at a dose of
500 mg/kg in morphine-injected mice showed a similar effect to
that of the untreated control (Fig. 2).
3.3. RGE restored the level of liver glutathione in morphine-treated
mice
It was reported that hepatic glutathione, which is involved in
the detoxiﬁcation of chemical compounds, signiﬁcantly decreased
after intraperitoneal injection of morphine [25]. Therefore, we
examined the level of this antioxidant substance in mice treated
with RGE before exposure to morphine. Mice treated with
J Ginseng Res 2016;40:445e452448morphine alone at 10 mg/kg showed a marked fall in glutathione
level; however, this was restored during pretreatment of RGE at
250 mg/kg and 500 mg/kg. Treatment of mice with RGE at a dose of
500 mg/kg alone showed neither an increase nor a decrease in the

























Con          Sal       RGE250   RGE500   RGE500
Fig. 3. Restorative effect of RGE on liver GSH content in morphine-treated mice. Mice
were treated with morphine (10 mg/kg), morphine plus RGE (250 mg/kg and 500 mg/
kg, i.p.), and RGE 500 mg/kg, i.p.). Data were expressed as mean SD (n¼ 8). # p< 0.05
compared with the control group. * p< 0.05 compared with the saline (morphine-



































Fig. 4. Inhibitory effects of ginsenosides on morphine withdrawal signs in rats. Rats were
600 mg/kg/d) for 7 d, and then treated with naloxone (10 mg/kg, i.p.) 6 h after the cessatio
naloxone. Data were expressed as mean SD (n¼ 6). # p< 0.05, compared with the saline-
with the morphine-only group. SD, standard deviation.3.4. Microinfusion of ginsenosides inhibited naloxone-precipitated
withdrawal symptoms in morphine-treated rats
To determine which ginsenosides were responsible for the ac-
tion of RGE against morphine dependence, biotransformed ginse-
nosideswere isolated and infused into rat brains. Ginsenosides Rh2,
Rg3, and compound K isolated from RGE showed reduced behav-
ioral patterns of morphine dependence in rats. Ginsenoside Rh2
and compound K revealed a strong effect on teeth chattering and
escaping behavior of prolonged morphine-infused rats when
compared with grooming and wet-dog shake (Fig. 4). In contrast,
Rg3 more signiﬁcantly retarded grooming and wet-dog-shake
symptoms of morphine withdrawal in rats.
3.5. Effect of ginsenosides Rh2, Rg3, and compound K on
phosphorylated NR1 and ERK1/2 in frontal cortical tissues of rat
brain and cultured cortical neurons
Previously, it was reported that morphine induced activation of
ERKs and NR1, which intricately interact with G protein-coupled m-
opioid receptors, leading to morphine-associated dependence and
tolerance [7]. Therefore, we sought to evaluate if morphine induced
protein expression levels of phospho-NR1 and phospho-ERK in the
frontal cortex regions of rat brain, and cultured cortical cells were
modulated by ginsenosides Rh2, Rg3, and compound K. We found
that p-ERK protein expression was signiﬁcantly reduced by the
three ginsenosides in the frontal cortical regions of rat brain. While
ginsenosides Rg3 and compound K signiﬁcantly attenuated p-NR1
expression in the frontal cortical regions of rat brain, the effect of
Rh2 was barely detected (Fig. 5). Likewise, the protein expression of











































infused with morphine (26 nmol/10 mL/h) and/or ginsenoside (10 mg/10 mL/h, about
n of morphine infusion. Withdrawal signs were observed for 30 min after injection of
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Fig. 5. Effects of ginsenosides on morphine-induced phosphorylation of NR1 and ERK in the frontal cortex region of rats. Rats were infused with morphine (26 nmol/10 mL/h) and/or ginsenoside (10 mg/10 mL/h, about 600 mg/kg/d) for
6 d. Frontal cortex region of rats were collected 8 h after the cessation of morphine infusion. Protein expressions of p-NR1, NR1, p-ERK, and ERK were examined using western blot analysis. Data were expressed as mean SD (n¼ 6).














Fig. 6. Changes in protein expressions of NR1 and ERK measured in cultured cortical neurons. Cells were pretreated with ginsenosides Rh2, Rg3, and CK (0.1mM, 1mM, and 5mM,
respectively) for 30 min and then exposed to morphine (1mM) for 6 h. Expressions of p-ERK and p-NR1 levels were examined using western blot analysis. All values are expressed as
mean SD from three independent experiments. # p< 0.05, compared with the vehicle group. * p< 0.05, compared with morphine alone. CK, compound K; ERK, extracellular
signal-regulated kinase; Mor, morphine; NR1, N-methyl-D-aspartate acid receptor subunit 1; SD, standard deviation.
J Ginseng Res 2016;40:445e452450ginsenosides and subjected to morphine. However, effects of gin-
senosides on activated ERK during morphine treatment in cortical
neurons were found to be negligible (Fig. 6).
4. Discussion
Given the importance of opioids to relieve moderate to severe
pain, their unwanted effects of drug dependence, analgesic
tolerance, and hyperalgesia remained an intimidating challenge.
Despite all these side effects, opioids such as morphine persist as
pharmacological cornerstone of modern pain therapy [26]. The
interplay of different receptors and kinases involved in morphine
action has paramount importance to understand the intricate
nature of dependence and tolerance. Apart from the classical
opioid receptors, morphine action to opioid receptor like-1 re-
ceptor, Toll-like receptor 4, and NR1 was reported for the mod-
ulation of pain and associated deleterious effects [27]. These side
effects of morphine could be mitigated by plant-derived com-
pounds such as resveratrol [11]. RGE and ginsenosides have
shown neuroprotective effects [28]; however, little is known
about their protective effect against morphine-induceddependence. We found that RGE along with biotransformed
ginsenosides Rh2, Rg3, and compound K ameliorated morphine-
induced dependence, such as jumping and CPP in mice, and
certain behavioral patterns, such as grooming, teeth chattering,
wet-dog shake, and escaping, in rats (Figs. 1, 2, 4); these obser-
vations were in line with those of previous reports indicating the
role of phytochemicals working against morphine withdrawal
symptoms in experimental animals [3,28]. Our ﬁnding was also
consistent with a previous work that shows the attenuating effect
of ginger extract on morphine-induced and naloxone-precipitated
withdrawal signs such as teeth chattering and jumping behav-
ioral patterns of mice [29]. Evidence indicated that treatment
with morphine is associated with the production of reactive
metabolites such as morphinone that can bind cellular gluta-
thione and reduces its bioavailability in the liver [30]. Therefore,
we determined if the level of glutathione was reduced during
morphine treatment and this effect was modulated by RGE. We
observed that RGE restored the level of glutathione to its normal
condition, and this ﬁnding was in line with that of a study
revealing that suppressed glutathione level in aged mice was
restored with red ginseng treatment [31].
T. Yayeh et al / Ginseng attenuated morphine dependence 451It was reported that activation of the NMDAReERK signaling
pathway in morphine induced CPP in rats [32]; therefore, we
investigated whether ginsenoside Rh2, Rg3, or compound K
modulated the protein expression of NR1 and ERK. We found that
phosphorylated ERK was inhibited by the aforementioned ginse-
nosides in the frontal cortex tissue of rats exposed to morphine.
Likewise, rats infused with ginsenosides Rg3 and compound K
showed a reduced protein expression of NR1 in morphine-exposed
groups when compared with Rh2, which was observed to reduce p-
ERK expression moderately and the NR1 protein expression faintly.
Compound K showed an excellent inhibitory effect on p-NR1 and p-
ERK compared with Rg3 and Rh2, in both the frontal cortical tissues
of rat brain and cultured cortical neurons. In fact, compound K has
shown diverse biological properties such as anticarcinogenic, anti-
inﬂammatory, antiallergic, antidiabetic, antiangiogenesis, anti-
aging, neuroprotective, and hepatoprotective effects [33].The cur-
rent discrepancies of ginsenoside actions on p-ERK or p-NR1 in the
brain might be due to their differential potency to modulate cell
signaling proteins; however, this warrants further investigation.
Ginsenosides alter behavioral changes by modulating neurons
that seem to be associated with the GABAA receptor complex. GABA
is a major inhibitory transmitter in the central nervous system.
Several lines of evidence show that the GABAA receptor complex is
involved in the development of opioid tolerance [15]; hence, it may
be a useful target for the treatment of drug abuse and dependence
[34,35]. Interestingly, the level of [3H]muscimol binding in the
cortex and cerebellum was increased by prolonged infusion of Rh2
and compound K [36], indicating the possibility of ginseng me-
tabolites to modulate the GABA receptor complex and thereby
ameliorating morphine dependence.
Wang et al [20] reported that Rg3 and compound K have strong
anticancer effects via impeding mitogen-activated protein kinase
(MAPK) signaling, which is in line with the diminished ERK phos-
phorylation by Rg3 and compound K noticed in the frontal cortex
region of rats. It was documented that morphine induces neuro-
inﬂammation via Toll-like receptor 4 [37]; therefore, the inhibitory
effect of Rg3 or compound K on ERK phosphorylation might follow
MAPK signaling downstream of Toll-like receptor 4.
Compelling evidence also indicated that opioid receptors are
part of G-protein-coupled receptors, and their activation by exog-
enous agonists such as morphine lead to the dissociation of Ga and
Gbg subunits, where the Gai subunit inhibits cyclic adenosine
monophosphate (cAMP) production and obliterates the cAMPePKA
pathway [38,39]. It is therefore intriguing to further investigate if
ginsenosides intervened downstream of opioid receptors, thereby
attenuating morphine dependence.
In conclusion, RGE and biotransformed ginsenosides Rh2, Rg3,
and compound K reduced behavioral patterns associated with
morphine dependence in mice and rats. Despite their differential
effects, ginsenosides Rh2, Rg3, and compound K reduced the levels
of activated NR1 and ERK proteins in the cortical regions of
morphine-treated groups, suggesting that their potential action
may pose against NMDAR and downstream signaling proteins.Conﬂicts of interest
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